English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 7 May 2015, 19:37 HKT/SGT
Share:
    

Source: Uni-Bio Science Group Limited
Uni-Bio Science Group Honored at HKIRA's IR Awards
Garners "Best IR Company - Small Cap" Award

HONG KONG, May 7, 2015 - (ACN Newswire) - Uni-Bio Science Group Limited ("Uni-Bio" or the "Group";HKEx code: 690) has garnered the "Best IR Company - Small Cap" Award after passing the stringent polling process of Hong Kong Investor Relations Association's ("HKIRA") first Investor Relations Awards ("IR Awards"). The accolade is testimony to the Company's dedicated efforts for excellence in corporate governance, effective policies and best practices in investor relations.

The inaugural IR Awards recognize Hong Kong listed companies and IR professionals for their achievement in investor relations. The 19 categories include Best IR Company, Best IR by Chairman/CEO, Best IR by CFO, Best IR Officer, Best IR Presentation Collaterals, Overall Best IR Company for large cap, mid cap and small cap, and Best IR Company for an IPO. Nominated individuals and companies have participated in an online survey earlier this year, while local and international buy-side and sell-side analysts, as well as fund managers voted for their choices. Nominees with the highest votes in each award category have been selected as award winners.

Mr. Kingsley Leung, Executive Director of Uni-Bio Science Group, said: "There are approximately 1,800 listed companies in the HKSE and more than 80% are considered 'Small Cap' with market capitalization below HK$10 billion. Amidst the very fierce competition for the award, we were honored to be nominated alongside 29 outstanding companies from various industries. Actually winning this accolade of 'Best IR Companies' under the 'Small Cap' category is one of the biggest milestones of the Group to date. Since the new directors and management came on board in the first half of last year, the Group has been dedicated to more effective communications with different stakeholders and the investment community via various measures. Highlights include voluntary announcements to enhance corporate transparency, conducting regular investor meetings and presentations and participating in analyst conferences. Winning this prestigious award demonstrates the greater trust earned among investors through our efforts. We would like to express our sincere gratitude to all of our friends in the investment community for their votes and continuous support in us. The honor will continue to motivate us further to pursue excellence in corporate governance and world-class IR standards."

HKIRA is a professional association comprising IR practitioners and corporate executives responsible for communications between corporate management and the investment community. Established in 2008, it advocates the setting of international standards in IR education, promotes best IR practices and strives to meet the professional development needs of those interested in pursuing the investor relations profession.

Contact:
Strategic Financial Relations Limited
Veron Ng      Phone: +852 2864 4831  Email: veron.ng@sprg.com.hk
Angelus Lau   Phone: +852 2864 4805  Email: angelus.lau@sprg.com.hk
Winkie Wong   Phone: +852 2114 4319  Email: winkie.wong@sprg.com.hk
Fax:   +852 2527 1196



Topic: Press release summary
Source: Uni-Bio Science Group Limited

Sectors: Daily Finance, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Uni-Bio Science Group Limited Related News
July 19, 2017 08:27 HKT/SGT
联康生物科技获香江大健康基金注资1.2亿港元 成为集团策略性股东
July 19, 2017 08:25 HKT/SGT
聯康生物科技獲香江大健康基金注資1.2億港元 成為集團策略性股東
July 19, 2017 08:23 HKT/SGT
HeungKong Great Health Fund I Injects HK$120 Million into Uni-Bio Science and Becomes its Strategic Shareholder
Feb 27, 2017 09:12 HKT/SGT
联康生物科技旗下药物获列入国家医保药品目录
Feb 27, 2017 09:11 HKT/SGT
聯康生物科技旗下藥物獲列入國家醫保藥品目錄
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575